Drug Search Results
More Filters [+]

Bronopol

Alternative Names: bronopol
Latest Update: 2024-02-01
Latest Update Note: PubMed Publication

Product Description

Bronopol, or 2-Bromo-2-nitro-1,3-propanediol, is an organic compound with wide-spectrum antimicrobial properties.  (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Bronopol)

Mechanisms of Action: Free Radical Agonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: France | Germany | Netherlands | Norway | Poland | Spain | Sweden | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: Allerderm
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Bronopol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Dermatitis, Contact|Dermatitis, Allergic Contact

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Dose Response Trial

P2

Active, not recruiting

Dermatitis, Allergic Contact|Dermatitis, Contact

2009-11-28

Safety and Efficacy Trial

P3

Active, not recruiting

Dermatitis, Contact|Dermatitis, Allergic Contact

2009-03-10

Recent News Events